Stanford researchers have developed an oral formula and method to reduce the risk of developing food allergies. This patented formula can reduce the risk of food allergy in different age groups when given as part of a normal daily diet.
Stanford researchers have developed a rapid, single-cell antimicrobial susceptibility testing (AST) platform that uses patient-derived body fluids or tissues to accurately identify antibiotic-resistant and tolerant bacteria.
Researchers at Stanford have developed a clinically applicable method of bone marrow conditioning for stem cell transplantation or treatment of hematologic malignancies.
Researchers at Stanford University have demonstrated rapid and accurate identification of extracellular vesicles (EVs) from different cell lines using an AI-assisted optical platform.
Stanford researchers have developed a targeted antibody-drug conjugate (ADC) platform to restore defective interleukin-2 receptor (IL-2R) signaling in regulatory T cells (Tregs), establishing proof of concept in preclinical models of autoimmunity.
Stanford researchers have developed a modular system of Synthetic cytokine receptors (SCRs), which are customizable receptors that mimic cytokine signals to precisely control immune cell behavior without the need for external cytokines.
High-grade gliomas, including glioblastoma and diffuse midline glioma are the most common malignant brain tumor types and leading causes of brain-tumor-related death in adults and children, respectively.
Necrotizing enterocolitis is a life-threatening illness almost exclusively affecting the gastrointestinal tract of neonates. It's caused by bacterial invasion of the intestinal wall, which leads to inflammation and cellular destruction of the wall of the intestine.
Oral mucositis (OM) is a painful side effect of chemoradiotherapy, especially in children and adolescents, with a high incidence rate of over 20%-40% and up to 90% in high risk patients.
Stanford researchers have developed a mouth-cooling device that prevents or reduces the degree of oral mucositis (OM), a painful side effect of chemotherapy, radiotherapy, autoimmune conditions, and infections.